healthy elderly with MCI
Conditions
Interventions
Bangle Rhizome 600 mg/day
Bangle Rhizome 300mg/day
placebo
Sponsors
Tokushima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Elderly people who are healthy and maintain their daily activities, but have mild cognitive decline, and who have given their consent to the study. Persons with an MMSE rating of 24 points or more and 27 points or less Organ function: Those who do not find any obvious abnormal values in blood tests
Exclusion criteria
Exclusion criteria: (1) Persons suffering from serious cerebrovascular disease, heart disease, liver disease, renal disease, gastrointestinal disease, infectious disease requiring notification, etc. (2) Those who are diagnosed with overt dementia (3) Chronic diseases (diabetes, heart disease, liver failure, renal failure, gastric / duodenal ulcer, colitis, Those who are being treated or taking medication due to Crohn's disease, cancer, etc.) (4) Persons with significant abnormalities in blood pressure measurement and blood test (5) Persons with severe anemia, malnutrition, or bleeding tendency (6) Those who frequently have diarrhea symptoms (7) Persons who may show allergic symptoms to the subject (8) Excessive smoking and alcohol addicts and those with extremely irregular lifestyle habits such as eating and sleeping (9) Those who are currently participating in other clinical trials or who have participated within one month (10) Others who are judged to be ineligible by the tester
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function evaluation | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in oral bacterial flora, taste threshold, dietary intake, ADL assessment | — |
Countries
Japan
Contacts
Public ContactRie Tsutsumi
Tokushima University Department of Metabolism and Nutrition
Outcome results
None listed